| Company Name: | Alembic Pharmaceuticals Ltd |
| OldName: | |
| Group : | |
| Address: | Corp Office |
| Alembic Road | |
| City: | Vadodara 390003 Vadodara Gujarat |
| Tel: | 0265-2280550 / 880 |
| Fax: | 2281229 |
| Mktg-Email : | alembic@alembic.co.in |
| HR-Email : | |
| Purchase-Email : | drigesh.mittal@alembic.co.in |
| Brands Owned : |
About the Company :
Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India.
Alembic’s manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh. The plant at Vadodara has the largest fermentation capacity in India. The Panelav facility houses the API and formulation manufacturing (both US FDA approved) plants. The plant at Baddi, Himachal Pradesh manufactures formulations for the domestic and non-regulated export market. The company has a state of the art Research Centre at Vadodara.
In July 2017, the company has set up a anti cancel manufacturing facility in Panelav in Halol in Gujarat.
Alembic Pharma receives USFDA approval for clobetasol propionate
Alembic Pharmaceuticals through its joint venture (JV) firm Aleor Dermaceuticals has received final USFDA approval for Clobetasol Propionate spray, used ...
Alembic raises ₹ 3500 million by private placement
Alembic Pharmaceuticals has raised ₹3500 million through allotment of non-convertible debentures (NCDs) on private placement basis. The NCD committee of ...
Alembic Pharma receives USFDA approval for travopost ophthalmic solution
Alembic Pharmaceuticals has received final USFDA approval for its abbreviated new drug application (ANDA) travoprost ophthalmic solution USP, 0.004%. The ...
Alembic Pharma receives USFDA approval for Desonide ointment
Alembic Pharmaceuticals through its joint venture firm Aleor Dermaceuticals has received USFDA approval for Desonide Ointment. The Desonide Ointment with ...
Alembic receives USFDA approval for olmesartan and hydrochlorothiazide
Alembic Pharmaceuticals has received final USFDA approval for two anti-hypertension tablets - olmesartan medoxomil tablets, 5 mg, 20 mg, and ...
Alembic Pharma receives USFDA approval for Pregabalin
Alembic Pharmaceuticals has received USFDA approval for Pregabalin Capsules, indicated for management of neuropathic pain associated with certain illnesses. The ...
Alembic Pharma receives USFDA approval for Clonazepam
Alembic Pharmaceuticals has received USFDA approval for Clonazepam orally disintegrating tablets which are used for treatment of seizures, adjunct in ...
Alembic Pharma receives USFDA approval for Solifenacin Succinate
Alembic Pharmaceuticals has received USFDA approval for Solifenacin Succinate tablets which are used for treatment of over-active bladder. The product ...
Alembic Pharma receives USFDA approval for Bromfenac Ophthalmic Solution
Alembic Pharmaceuticals has received USFDA approval from for Bromfenac Ophthalmic Solution, used for treatment of post-operative inflammation and reduction of ...
Alembic Pharma receives USFDA approval for Oseltamivir Phosphate
Alembic Pharmaceuticals has received final USFDA approval for Oseltamivir Phosphate capsules, used for treatment of influenza infection. The drug is ...
Alembic Pharmaceuticals receives USFDA approval for Carbidopa and Levodopa extended-release tablets
Alembic Pharmaceuticals has received USFDA approval for Carbidopa and Levodopa extended-release tablets which is used for treatment of Parkinson’s disease ...
Alembic Pharma receives USFDA approval for Tadlafil
Alembic Pharmaceuticals has received final USFDA approval for Tadalafil tablets, indicated for the treatment of erectile dysfunction. The drug will ...
Alembic Pharma receives USFDA approval for Azelastine Hydrochloride
Alembic Pharmaceuticals has received USFDA approval for Azelastine Hydrochloride Ophthalmic Solution used for the treatment of allergic conjunctivitis. The drug ...
Alembic receives USFDA approval for Acetazolamide
Alembic Pharmaceuticals has received final USFDA approval for Acetazolamide extended-release capsules, used for the treatment of various kinds of glaucoma ...
Alembic Pharma receives USFDA approval for Pramipexole Dihydrochloride tablets
Alembic Pharmaceuticals has received final USFDA approval for Pramipexole Dihydrochloride extended-release tablets used for the treatment of Parkinson’s disease. The ...
Alembic Pharma receives USFDA approval for Temazepam capsules
Alembic Pharmaceuticals has received USFDA approval for Temazepam capsules which is used for the treatment of insomnia. The drug will ...
Alembic Pharma receives USFDA approval for Olopatadine Hydrochloride
Alembic Pharmaceuticals has received USFDA approval for Olopatadine Hydrochloride ophthalmic solution, used to treat allergic conjunctivitis. The approved product is ...
Alembic Pharma recieves USFDA approval for Lacosamide
Alembic Pharmaceuticals Ltd has received final USFDA approval for its Lacosamide tablets, which is indicated as adjunctive therapy in patients ...
Alembic Pharma receives USFDA approval for Zolmitriptan
Alembic Pharmaceuticals has received USFDA approval for Zolmitriptan Orally Disintegrating tablets, used for the treatment of migraine, in the American ...
Alembic Pharma receives USFDA approval for Telmisartan and Amlodipine
Alembic Pharmaceuticals has received USFDA approval for its Telmisartan and Amlodipine tablets in the strengths of 40mg/5 mg, 40mg/10 mg, ...
Alembic Pharma receives USFDA approval for fenofibric acid delayed release capsules
Alembic Pharmaceuticals has received final USFDA approval for Fenofibric acid delayed-release capsules used for lowering high cholesterol and increasing good ...
Alembic Pharma receives USFDA approval for doxycycline
Alembic Pharmaceuticals has received the final USFDA approval for Abbreviated New Drug Application (ANDA) of anti-bacterial Doxycycline capsules USP 75 ...
Alembic receives USFDA approval for acyclovir ointment
Alembic Pharma has received USFDA approval for its Acyclovir ointment USP, used for the treatment of genital herpes. The ointment ...
Alembic Pharma acquires US based West Caldwell
Alembic Pharmaceuticals has acquired a US based generic drug developer West Caldwell, New Jersey. With this acquisition Alembic will now ...
Alembic Pharma plans expansion programme at Panelav unit
Alembic Pharma is planning to expand its existing unit in Panelav village in Halol Tehsil in Panchmahal district of Gujarat ...
| Personnel | |
| Amit Shah | – Sr. Manager |
| R S Joshi | – Asst. Gen. Mgr |
| Chirayu Amin | – CEO |
| Mitanshu Shah | – Senior Vice President Finance |
| Ahalgama Jignesh | – Formulation and Development |
| Dr. Abhay Gaitonde | – Senior Vice President (Formulations) |
| Fomi Dwivedi | – Assistant Manager Learning Development |
| Virendra Srivastava | – Associate Vice President – Regulatory Affairs |
| Piyush Kunal | – Assistant General Manager Planning & Logistics |
| Vishal Kale | – Production Executive |
| Vivek V | – Product Manager |
| Shriniwas Shantkumar Yeramwar | – Assistant Manager – Project Management |
| Sanjay Katre | – Quality Compliance Manager |
| Vivek Avasatthi | – Research Scientist |
| Mitesh Shah | – Manager |
| Mayuri Sathe | – Sr Product Manager |
| Debashish Kar, | – Head Quality Assurance |
| Ramanbhai Amin | – Director |
| Malika Chirayu Amin | – Director |
| Udit Chirayu Amin | – Director |
| Sameer Subhash Khera | – Director |
Other Office Address
| Plant Survey No. 842 /843, Village Kharkhadi Padra Village Karkhadi 391450 Padra Vadodara Gujarat |
| Plant Plot No. 21, 22 , EPIP – Phase I Jhamajri , Baddi, Tehsil Baddi 173205 Solan Himachal Pradesh |
| Plant Panelav, Tal. Halol, Panelav 389356 Halol Panchmahals Gujarat |
| Plant Alembic Road Vadodara 390003 Vadodara Gujarat Tel : 0265-2280550 /880 Fax : 2281229 Email : alembic@alembic.co.in |
| Corp Office Alembic Road Vadodara 390003 Vadodara Gujarat 0265-2280550 / 880 2281229 |
Leave a Reply